KEWAUNEE SCIENTIFIC CORP /DE/ KEQU
KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU) earns a Piotroski F-score of 5/9 (mixed financial health), with an Altman Z″ in the safe zone. It pays a dividend yielding 1.02% (safety: no dividend). FY2026 revenue was $282.0M at a 3.4% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Beneish M-score: -2.71 — low (below −2.22 — no manipulation red flag) . A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.
Smart money · insiders, last 12 months
Open-market insider purchases minus sells (SEC Form 4) — real buying with their own money is a bullish “smart money” signal; grants and option exercises are excluded.
How it ranks in Manufacturing · percentile among 1957 companies
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 5/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · safe zone
| Component | Value |
|---|---|
| Working capital / assets | 0.32 |
| Retained earnings / assets | 0.384 |
| EBIT / assets | 0.094 |
| Equity / liabilities | 0.757 |
Sector peers · similar-size Manufacturing companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| KEQU | KEWAUNEE SCIENTIFIC CORP /DE/ | 5/9 | 4.78 | 10.7 | +17.3% |
| RSCF | REFLECT SCIENTIFIC, INC. | 1/9 | -17.79 | — | — |
| VFS | VinFast Auto Ltd. | 4/9 | -13.01 | — | +57.9% |
| TM | TOYOTA MOTOR CORP/ | 7/9 | 2.55 | — | -1% |
| HMC | HONDA MOTOR CO LTD | 6/9 | 2.79 | — | +19.9% |
| SONY | Sony Group Corp | 6/9 | 0.86 | — | +9% |
| CAJFF | CANON INC | 6/9 | — | — | +14.7% |
About KEWAUNEE SCIENTIFIC CORP /DE/
Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments: Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks. The company's laboratory products are used in chemistry, physics, biology, and other general science laboratories in the pharmaceutical, biotechnology, industrial, chemical, commercial, educational, government, and health care markets; and technical products are used in facilities manufacturing computers and light electronics and by users of computer and networking furniture. It sells its products through dealers, its subsidiaries, and a national stocking distributor. The company was founded in 1906 and is headquartered in Statesville, North Carolina.
FAQ
Is KEQU financially healthy?
KEWAUNEE SCIENTIFIC CORP /DE/'s Piotroski F-score is 5/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the safe zone.
Does KEQU pay a dividend, and is it safe?
Yes. KEWAUNEE SCIENTIFIC CORP /DE/ pays a dividend yielding about 1.02% with a None payout ratio, rated “no dividend” for safety.
How profitable is KEQU?
In FY2026, KEWAUNEE SCIENTIFIC CORP /DE/ had a net margin of 3.4% and a return on equity of 12.5%.
Is KEQU overvalued or undervalued?
KEWAUNEE SCIENTIFIC CORP /DE/ trades at about 11.3× trailing earnings — below its 10-year norm (10-year range 6.7×–66.6×, median 12.6×). Stocktoria reports the data, not buy/sell advice.
Is KEQU a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on KEWAUNEE SCIENTIFIC CORP /DE/: a Piotroski F-score of 5/9, an Altman Z″ in the safe zone, a P/E of about 10.7×, a dividend yield of 1.02%. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2026-04-30. Facts plus Stocktoria's own computed scores — not investment advice.